A long-running theme of billionaire investing is the idea of “living forever”, or at least much longer than our current life-span, and the latest biotech group trying to make this happen has received a big investment from a number of family offices.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in
